Clinical Trials Directory

Trials / Unknown

UnknownNCT03388424

Quantification of Microbiota in Health and Diseases

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
University of Catanzaro · Academic / Other
Sex
All
Age
4 Years – 90 Years
Healthy volunteers
Accepted

Summary

Microbiota consists of trillions of microorganisms located in all the biological cavity. The relationships between individual health status and microbiota are based on a sort of "mutual cooperation." The balance of the microbiota can be compromised by various factors such as environmental, psycho-physical stress, malnutrition (over or low), breastfeeding, chronic diseases, oncology and pharmacological treatments (especially antibiotics and chemotherapics). The impact of dysbiosis on today's society affects over 70% of the world population

Detailed description

Intestinal microbiota is defined as the strongest modulator of the human genome and it is considered the "second brain" of our organism for its bi-directional communication with the central nervous system. Microbiota consists of trillions of microorganisms located in all the biological cavity, In the intestine it is distributed in ecological niches having multiple metabolic activities which influence individual health. Microbiota acts as barrier against pathogens, regulating the absorption of nutrients, the production of energy and the development of the immune system4. Intestinal bacteria are generally divided into 4 Phylum: Firmicutes, Actinobacteria, Proteobacteria and Bacteriodetes, in which their proportion shows a correlation with individuals health status. When in equilibrium among them, these bacteria are essential for the good health of the digestive tract, the good function of immune system and for brain performace. The relationships between individual health status and microbiota are based on a sort of "mutual cooperation." The balance of the microbiota can be compromised by various factors such as environmental, psycho-physical stress, malnutrition (over or low), breastfeeding, chronic diseases, oncology and pharmacological treatments (especially antibiotics and chemotherapics). This disequilibrium leads to altered capability of bacteria to properly extract calories from food affecting the trend of many pathophisilogical status such as obesity, allergic states, inflammatory bowel syndromes cardiovascular diseases, metabolic, oncological and neurodegenerative diseases. The impact of dysbiosis on today's society affects over 70% of the world population

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTquantification of microbiotaFor each group a sample of biological sample will be take and will be analyzed using the n-counter flex platform in order to quantify disbiosis

Timeline

Start date
2017-11-22
Primary completion
2020-05-21
Completion
2022-11-21
First posted
2018-01-03
Last updated
2020-09-16

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03388424. Inclusion in this directory is not an endorsement.